Amgen, Inc.- Strategy and SWOT Report
MarketLine, November 2011, Pages: 55
Amgen, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company.
Features:
- Detailed information on Amgen, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Amgen, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Amgen, Inc. including a breakdown and examination of key business segments
- Intelligence on Amgen, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Amgen, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
Amgen is the leading biotechnology company engaged in the discovery, development, manufacture, and marketing of innovative human therapeutics. The company mainly focuses in the areas of cancer, kidney disease, rheumatoid arthritis and other serious illnesses. The company primarily operates in the US. It is headquartered in Thousand Oaks, California and employed 17,400 people as of December 31, 2010. The company recorded revenues of $15,053 million during the financial year (FY) ended December 2010, an increase of 2.8% over 2009. The operating profit of the company was $5,545 million during FY2010, an increase of 0.7% over 2009. The net profit was $4,627 million in FY2010, an increase of 0.5% over 2009.
Reasons to Purchase:
- Gain understanding of Amgen, Inc. and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Amgen, Inc. as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Amgen, Inc.’s business structure, strategy and prospects
Company Snapshot
Amgen, Inc.: Company Overview
Amgen, Inc.: Overview and Key Facts
Amgen, Inc.: Overview
Amgen, Inc.: Key Facts
Amgen, Inc.: Key Employees
Amgen, Inc.: Key Employee Biographies
Amgen, Inc.: Major Products and Services
Amgen, Inc.: Company History
Amgen, Inc.: Management Statement
Amgen, Inc.: Locations and Subsidiaries
Amgen, Inc.: Key Competitors Amgen, Inc.: Company Analysis
Amgen, Inc.: Business Description
Amgen, Inc.: SWOT Analysis
Amgen, Inc.: SWOT Overview
Amgen, Inc.: Strengths
Amgen, Inc.: Weaknesses
Amgen, Inc.: Opportunities
Amgen, Inc.: Threats
Amgen, Inc.: Corporate Financial Deals Activity
Amgen, Inc.: Financial Deals Overview
Amgen, Inc.: Targets and Partners
Amgen, Inc.: Top Deals 2007 -YTD-2012
Amgen, Inc.: Advisors
Amgen, Inc.: Top Legal Advisors
Amgen, Inc.: Top Financial Advisors
Amgen, Inc.: Mergers and Acquisitions
Amgen, Inc.: Corporate Venturing
Amgen, Inc.: Partnership
Amgen, Inc.: Divestments Amgen, Inc.: Recent Developments
Amgen, Inc.: News and Events Summary
Amgen, Inc.: Business Expansion
Amgen, Inc.: Contracts
Amgen, Inc.: Corporate Governance
Amgen, Inc.: Financial Performance
Amgen, Inc.: Regulatory and Legal Events
Amgen, Inc.: Research & Development
Amgen, Inc.: Strategy and Operations Appendix
Contact Us
Methodology
Definitions
About Datamonitor List of Tables Table 1: Amgen, Inc.: Key Facts Table 2: Amgen, Inc.: Key Employees Table 4: Amgen, Inc.: Key Competitors Table 5: Amgen, Inc.: Deal Activity by Deal Type - Volume (TTM-) Table 6: Amgen, Inc.: M&A Activity by Geography (TTM-) Table 7: Amgen, Inc.: Deal Activity by Deal Type - Volume (2008 - YTD-2012) Table 8: Amgen, Inc.: M&A Average Deal Size - Value (US$m) Table 9: Amgen, Inc.: Targets and Partners Table 10: Amgen, Inc.: Top Deals 2007 -YTD-2012 Table 11: Amgen, Inc.: Legal Advisor Ranking by Value (US$m) Table 12: Amgen, Inc.: Financial Advisor Ranking by Value (US$m) Table 13: Amgen, Inc.: M&A Volume and Value Trend (2008 - YTD-2012) Table 14: Amgen, Inc.: M&A Activity by Geography (2008 - YTD-2012) Table 15: Amgen, Inc.: Corporate Venturing Volume and Value Trend (2008 - YTD-2012) Table 16: Amgen, Inc.: Corporate Venturing by Geography (2008 - YTD-2012) Table 17: Amgen, Inc.: Partnership Volume and Value Trend (2008 - YTD-2012) Table 18: Amgen, Inc.: Partnership Trend by Deal Type (2008 - YTD-2012) Table 19: Amgen, Inc.: Divestments Volume and Value Trend (2008 - YTD-2012) Table 20: Amgen, Inc.: Divestments by Geography (2008 - YTD-2012) Table 21: Amgen, Inc.: News and Events Summary Table 22: Amgen, Inc.: Business Expansion Table 23: Amgen, Inc.: Contracts Table 24: Amgen, Inc.: Corporate Governance Table 25: Amgen, Inc.: Financial Performance Table 26: Amgen, Inc.: Regulatory and Legal Events Table 27: Amgen, Inc.: Research & Development Table 28: Amgen, Inc.: Strategy and Operations List of Figures Figure 1: Amgen, Inc.: Deal Activity by Deal Type - Volume (TTM-) Figure 2: Amgen, Inc.: M&A Activity by Geography (TTM-) Figure 3: Amgen, Inc.: Deal Activity by Deal Type - Volume (2008 - YTD-2012) Figure 4: Amgen, Inc.: M&A Average Deal Size - Value (US$m) Figure 5: Amgen, Inc.: M&A Volume and Value Trend (2008 - YTD-2012) Figure 6: Amgen, Inc.: M&A Activity by Geography (2008 - YTD-2012) Figure 7: Amgen, Inc.: Corporate Venturing Volume and Value Trend (2008 - YTD-2012) Figure 8: Amgen, Inc.: Corporate Venturing by Geography (2008 - YTD-2012) Figure 9: Amgen, Inc.: Partnership Volume and Value Trend (2008 - YTD-2012) Figure 10: Amgen, Inc.: Partnership Trend by Deal Type (2008 - YTD-2012) Figure 11: Amgen, Inc.: Divestments Volume and Value Trend (2008 - YTD-2012) Figure 12: Amgen, Inc.: Divestments by Geography (2008 - YTD-2012)
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
